Rank 1 • AI & Clinical Intelligence
Tempus
Operates a proprietary data and AI platform to power precision medicine and clinical decision support through genomic sequencing.
Visit website- Signal Score
- 94.8
- Total raised
- $1400M
- Stage
- Public
- Founded
- 2015
- Headquarters
- Chicago, USA
- Region
- North America
Their signal
Following its successful 2024 IPO, Tempus remains a powerhouse, leveraging one of the world's largest clinical-genomic datasets to transform cancer care and personalized medicine.
Signal Score 94.8editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in AI & Clinical Intelligence
Did we miss something?
Change, add or remove details on this company. Our desk reviews every request.
Figures are subjective research desk estimates compiled from public sources and refreshed monthly, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.